Added to YB: 2026-10-05
Pitch date: 2026-10-01
LNSR [bullish]
LENSAR, Inc.
-8.22%
current return
Author Info
Trident Opportunities writes about deep value and special situation investment opportunities. Sign up for the newsletter.
Company Info
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Market Cap
$81.0M
Pitch Price
$6.57
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.36
P/E
12.42
EV/Sales
1.39
Sector
Health Care Equipment and Supplies
Category
growth
Portfolioupdate Q3 - 2026 - +40,4% YTD - LENSAR, Inc.
LNSR (hold): LENSAR’s adoption supports the assumption of a technological or operational edge: backlog was steadily increasing, procedure counts are rising, and the company was consistently taking market share and continues to do so in the U.S. The key uncertainty is international opportunity, where SAM is more relevant, competition is fierce, Alcon has its own system, and winning back European customers and distributors is far from guaranteed.
Read full article (1 min)